382 results on '"Michieli M."'
Search Results
2. The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant
3. Trunk muscle coactivation changes in patient with multiple myeloma undergoing vertebral consolidation surgery: a study performed by using movement analysis technologies
4. P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL
5. Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk
6. The effect of a passive exoskeleton on trunk co-activation during liftings at different risk levels
7. Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
8. Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation
9. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party
10. Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
11. S300: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD)
12. P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT
13. S221: BORTEZOMIB TO R-DHAP COMPARED TO R-DHAP IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE TO STEM CELL TRANPLANTATION: FINAL RESULTS OF PHASE II RANDOMIZED FIL-VERAL12
14. AUTOLOGOUS TRANSPLANT IN ELDERLY PATIENTS WITH R/R AGGRESSIVE LYMPHOMA SELECTED BY SIMPLIFIED CGA: THE RECANZ PROSPECTIVE PHASE 2 STUDY BY THE FONDAZIONE ITALIANA LINFOMI
15. BU/melphalan and auto-SCT in AML patients in first CR: a ‘Gruppo Italiano Trapianto di Midollo Osseo (GITMO)’ retrospective study
16. GAMMA-HERPESVIRUS LOAD AS SURROGATE MARKER OF PRECOCIOUS DEATH IN HIV-POSITIVE LYMPHOMA PATIENTS SUBMITTED TO HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: PH-P496
17. IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients
18. Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
19. Long term cryopreservation in 5% DMSO maintains unchanged CD34+ cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation
20. Dendritic cell recovery after autologous stem cell transplantation
21. Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia
22. Autologous bone marrow transplantation in non-Hodgkin’s lymphoma patients: effect of a brief course of G-CSF on harvest and recovery
23. Multidrug resistance modulation in vivo: The effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia
24. Comprehensive geriatric assessment of elderly patients with lymphomas candidate to autologous bone marrow transplantation. A single-centre experience: P871
25. Outcome of Hodgkinʼs lymphoma and aggressive non-Hodgkin lymphoma patients refractory to salvage chemotherapy: P862
26. Long-term immune reconstitution in HIV-positive relapse/ refractory lymphoma patients after autologous stem cell transplantation: P736
27. Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support
28. A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: a single institution experience
29. Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia
30. Effectiveness of autologous bone marrow transplantation in relapsed or resistant HIV-related lymphomas: a monocentre Italian experience at a national cancer centre: O261
31. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor
32. Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation
33. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial
34. Is high-dose chemotherapy with peripheral stem cell rescue a suitable option for elderly patients affected by aggressive non-Hodgkinʼs lymphoma?
35. High dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for HIV-associated lymphoma in patients on highly active antiretroviral therapy. A multicentre study
36. CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection
37. Oxaliplatin (OXA) und 5-Fluorouracil (5-FU) bei Leberzellkarzinom (HCC): 2343
38. Vergleich von Wirksamkeit und Verträglichkeit des FOLFOX2-Schemas bei älteren und jüngeren Patienten mit fortgeschrittenem Kolorektalkarzinom (COL): 2195
39. INNOVATIVE CHEMOTHERAPY IN HEPATOCARCINOMA (HCC)
40. Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
41. EP-1246: Radiotherapy after autologous stem cell transplant in recurrent or refractory hodgkin's lymphoma
42. HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA: A RETROSPECTIVE STUDY OF THE EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION (EBMT)
43. Real life' use of Plerixafor: a multicenter north east Italy experience
44. PO-0665: Compliance with ILROG guidelines in the treatment of extranodal lymphomas; an internal plans review
45. PO-0666: Comparing the efficacy of low-dose radiotherapy in patients with aggressive and indolent lymphomas
46. Oncologic drug shortages also in Italy
47. Will Molecular Biology Contribute to Refine Prognosis and to Select Treatment?
48. Liposome-encapsulated daunorubicin for PGP-related multidrug resistance
49. Conventional-dose (CDCT) versus high-dose chemotherapy (HDCT) in the salvage management of relapsed pure seminoma: results from an international database
50. SHORT-TERM THALIDOMIDE INCORPORATED INTO DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTATION IMPROVES OUTCOMES IN COMPARISON WITH DOUBLE AUTOTRANSPLANTATION FOR MULTIPLE MYELOMA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.